Refractory classic juvenile pityriasis rubra pilaris successfully treated with a combination of etanercept and methotrexate
- 20 April 2020
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (3), e13431
- https://doi.org/10.1111/dth.13431
Abstract
Click on the article title to read more.Keywords
This publication has 6 references indexed in Scilit:
- Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practiceAdvances in Dermatology and Allergology, 2019
- Systemic therapies of pityriasis rubra pilaris: a systematic reviewJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2018
- Biologics for pityriasis rubra pilaris treatment: A review of the literatureJournal of the American Academy of Dermatology, 2018
- A case of juvenile pityriasis rubra pilaris type III successfully treated with etanerceptDermatologic Therapy, 2017
- Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigationDermatologic Therapy, 2017
- Epidemiologic, Clinicopathologic, Diagnostic, and Management Challenges of Pityriasis Rubra PilarisJAMA Dermatology, 2016